Azenta's Q3 Earnings: Will It Beat Expectations?
Update: 2025-11-20
Description
Azenta, a life sciences company, is set to release its latest financial results this Friday, following a lackluster performance in the previous quarter where it missed revenue expectations by nearly four percent. Analysts anticipate a four percent year-over-year revenue growth for this quarter, reaching one hundred fifty-six point seven million dollars, and expect adjusted earnings to be twenty cents per share. Despite consistent analyst predictions, Azenta has a history of missing Wall Streets revenue estimates. In contrast, competitors like Medpace and UFP Technologies have reported positive results, leading to significant stock price increases. Azentas stock, however, has fallen by over eight percent in the last month, currently trading below the average analyst price target of thirty-five dollars and seventeen cents.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
